2030 Clinical Research Immune Response 
PerkinElmer
JANUARY 25, 2023
Recent research shows that individuals with long COVID were more likely to have autoimmunity markers in their blood than those who had recovered quickly or never contracted the virus. The emerging field of metagenomics in clinical research settings also shows promise.
Codon
OCTOBER 27, 2024
In 2014, the World Health Organization (WHO) proposed an initiative called the End TB Strategy , aimed at reducing cases by 80 percent, deaths by 90 percent, and diagnostic/treatment costs by 100 percent by 2030. Interferon gamma release assays pick up an immune response to the infection. A sputum test stain for M. tuberculosis.
Expert insights. Personalized for you.
52 
Let's personalize your content